Sign in

CIK 0001781983

  • Non-accelerated filer
  • Smaller reporting company

Aprea Therapeutics, Inc.

Sign in to watch
Ticker
APRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 215-948-4119
Business address
3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-03-12 Gilad Oren President/CEO Grant or award +20,175 393,895
2026-03-12 Gilad Oren President/CEO Grant or award · Stock Options (Right to Buy) +80,700 80,700
2026-01-30 Gilad Oren President/CEO Purchase +28,100 $0.89 $25K 373,720
2026-01-30 Gilad Oren President/CEO Purchase · Common Warrant +28,100 28,100
2025-12-10 Gilad Oren President/CEO Purchase · Pre-Funded Warrant +21,459 $1.17 $25K 21,459
2025-12-10 Gilad Oren President/CEO Purchase · Common Warrants +21,459 21,459
2025-04-03 Gilad Oren President/CEO Purchase +3,003 $1.87 $6K 343,123
2025-04-03 Gilad Oren President/CEO Purchase +2,497 $1.80 $4K 345,620
2025-03-27 Gilad Oren President/CEO Grant or award +6,725 340,120
2025-03-27 Gilad Oren President/CEO Grant or award · Stock Options (Right to Buy) +26,900 26,900
2024-10-23 Gilad Oren President/CEO Purchase +500 $3.92 $2K 333,395
2024-10-15 Gilad Oren President/CEO Purchase +250 $2.90 $725 332,895
2024-10-14 Gilad Oren President/CEO Purchase +1,000 $2.59 $3K 332,645
2024-10-10 Gilad Oren President/CEO Purchase +150 $2.54 $381 331,645
2024-03-28 Gilad Oren President, CEO Grant or award +6,725 331,495
2024-03-28 Gilad Oren President, CEO Grant or award · Stock Options (Right to Buy) +26,900 26,900
2024-03-13 Gilad Oren President, CEO Purchase +2,000 $7.29 $15K 324,770
2024-03-13 Gilad Oren President, CEO Purchase · Tranche A Warrant +1,000 1,000
2024-03-13 Gilad Oren President, CEO Purchase · Tranche B Warrant +1,000 1,000
2023-03-09 Gilad Oren President, CEO Grant or award +4,000 322,770

Page 1 of 2 · 25 trades